PDS Biotechnology (PDSB) Tops Q2 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
PDS Biotech Reports Second Quarter 2022 Financial Results and Provides Business Update
August 8, 2022 7:00 AM EDTAnnounced results from two of the ongoing Phase 2 clinical trials of PDS0101 in multiple, difficult-to-treat HPV16-related cancers presented at the American Society of Clinical Oncology meetingPromising pre-clinical data on universal flu vaccine program presented at American Society of Virology meeting Company to host conference call and webcast today at 8:00 AM EDT
FLORHAM PARK, N.J., Aug. 08, 2022 (GLOBE NEWSWIRE) --... More



